HEALTHY VOLUNTEERS

J&J eyes 1 billion doses of potential COVID-19 shot in 2021, weighs challenge trials

Large-scale trials are set to start by the beginning of October and J&J aims to have results on the vaccine's efficacy between the end of this year and mid-2021